🇺🇸 Nebivolol Tablets in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 4
Most-reported reactions
- Anaemia — 1 report (25%)
- Asthenia — 1 report (25%)
- Hyperkalaemia — 1 report (25%)
- Muscle Spasms — 1 report (25%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Nebivolol Tablets approved in United States?
Nebivolol Tablets does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Nebivolol Tablets in United States?
Ain Shams University is the originator. The local marketing authorisation holder may differ — check the official source linked above.